Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/22/2025

Glycopyrrolate Dosing Guidelines

Palliative Care Applications

  • The National Comprehensive Cancer Network recommends glycopyrrolate 0.2-0.4 mg IV or subcutaneous every 4 hours as needed to reduce excessive respiratory secretions in dying patients 1, 2, 3
  • Alternative dosing is 0.4 mg subcutaneous every 4 hours PRN for the same indication 2
  • Glycopyrrolate 0.2-0.4 mg IV every 4 hours PRN can be used as an anticholinergic agent for diarrhea management in palliative care 1
  • Consider glycopyrrolate for persistent Grade 2-4 diarrhea when other interventions fail 1

Pediatric Dosing Considerations

  • Atropine or glycopyrrolate may be used to prevent increased salivation during ketamine sedation in pediatric patients, according to the American Academy of Pediatrics 4, 5, 6

Glycopyrrolate Dosage and Administration

Dosing Guidelines for Specific Indications

  • For diarrhea management in palliative care, consider glycopyrrolate 0.2-0.4 mg IV every 4 hours as needed, as recommended by the National Comprehensive Cancer Network 7
  • For anticholinergic premedication in anesthesia, intravenous atropine and glycopyrrolate are acceptable anticholinergic medications to prevent bradycardia, arrhythmia, or occasional ECT-induced cardiac asystole, according to the American Academy of Child and Adolescent Psychiatry 8

REFERENCES

1

palliative care version 1.2016. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2016

2

palliative care version 1.2016. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2016

3

palliative care. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2012

7

palliative care version 1.2016. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2016

8

practice parameter for use of electroconvulsive therapy with adolescents. [LINK]

Journal of the American Academy of Child and Adolescent Psychiatry, 2004